Status:
ACTIVE_NOT_RECRUITING
PCOS & Insulin Resistance Exercise Study
Lead Sponsor:
University of California, San Francisco
Conditions:
Polycystic Ovary Syndrome
Insulin Resistance
Eligibility:
FEMALE
18-50 years
Phase:
NA
Brief Summary
This study evaluates the feasibility and metabolic effects of implementing a structured exercise program in women with polycystic ovary syndrome and insulin resistance. Participants will be randomized...
Detailed Description
Polycystic ovary syndrome (PCOS) is a common endocrine disorder with an incidence of 5-8% in reproductive aged women. PCOS is characterized by a collection of signs and symptoms, and as defined by the...
Eligibility Criteria
Inclusion
- Diagnosis of PCOS as defined by the 2003 Rotterdam criteria
- Presence of insulin resistance as defined by HOMA IR (Insulin Resistance) \> 2.0 or fasting insulin ≥ 12 milliunits per liter (mU/L)
- Physician judges that patient is in adequate physical condition to complete exercise program
Exclusion
- Age \<18 years old or \>50 years old
- BMI \>40 kg/m2
- Current tobacco user
- Presence of the following pre-existing co-morbid conditions: diabetes mellitus type 2, uncontrolled hypertension (\>140/90mmHg), cardiovascular disease
- Presence of musculoskeletal injury or disease that would interfere with patient's ability to complete exercise program
- Current pregnancy or planning to attempt to conceive in the next 3 months
Key Trial Info
Start Date :
March 1 2015
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 1 2025
Estimated Enrollment :
47 Patients enrolled
Trial Details
Trial ID
NCT02303470
Start Date
March 1 2015
End Date
February 1 2025
Last Update
June 20 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
UCSF Center for Reproductive Health
San Francisco, California, United States, 94158